Copyright © 2021, Diaceutics. All rights reserved

DXRX Data Solutions:

Patient Mapping

Get Access

DXRX Patient Mapping 

DXRX Patient Mapping is designed to deliver deep analysis on disease testing and the diagnostic testing journey of a patient to give actionable insights for your commercial decisions. 

It enables you to view real world diagnostic test results at a patient level – not summary or aggregate data – including actual test results and turnaround times as well as standardized results.

Get Access

A number of recommendations provided by the European IVDR Working group to:

Access weekly data feed enabling you to make critical decisions in a time-sensitive manner as the market opportunity develops or flexes, enabling greater commercial outcomes.

Understand the current testing journey by disease or stage in minutes to identify potential barriers and leakage points that need to be overcome in order to achieve maximum new diagnostic testing uptake rates.

Obtain details on both the ordering physician and the treating physician.

Identifying the geographical areas where there are insufficiently tested patients, or the diagnostic market size of any given disease, as well as how and when that market is changing.

Access to actual test results and turn around times as well as standardised results  indicating if a test result is positive or negative.

Understand more about the patient journey in minutes with DXRX

DXRX - The Diagnostic Network®

An end-to-end solution for the development and commercialization of precision medicine diagnostics

Discover DXRX

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

About Diaceutics


Click on any of the buttons in the information page. These will direct you to register on DXRX

Register on DXRX

Create a profile for your organization on DXRX

Login to get access to the DXRX Knowledge Hub including IVDR Paper, ISPOR abstract and more plus discover how to get access to sponsored programs and collaborations 

For further information on how we will be capturing your personal data please see privacy statement

Need help? Email us on

Access on DXRX

How to Access reports and abstracts on DXRX - The Diagnostic Network®

New ISPOR 2021 Abstract : 

"The Potential Healthcare and Economic Impact of The Implementation of the In Vitro Diagnostic Regulation on Non-Small-Cell Lung Cancer Patients in the European Union" 



Understand the potential impact of IVDR on patients with metastatic NSCLC in the EU.

The annual cost of treating the patient NSCLC cohort were determined and then the fraction of LDTs employed to calculate the number of patients and costs to pharma that were under threat of having therapy withheld.

Scenarios at 10% to 100% LDT failure were analysed resulting in 4,255 to 42,546 NSCLC patients potentially losing therapy at a cost to pharma revenue of €335M to €3.3B.

How to Access

DXRX – The Diagnostic Network®

DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Enabled by DXRX, Diaceutics provides the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics.

Authors: Gwendolyn Courtois MSc2, Lauren Parnham2, Katherine E. Keating PhD2, Peter Riccelli PhD1, Dave Smart PhD2, Susanne Munksted MSc2, Jordan Clark MPhil2, Keith Kerr MD, FRCPath3

Patient Mapping Demo 

Please use the form to register your interest in a demonstration of DXRX Patient Mapping to you/your organization.

Once you submit the form, our customer success team will contact you with a demonstration slot.

If you have any further initial requirements or wish to discuss your demonstration please email our customer success team on

*Registration on DXRX will take up to 24-48h

Should you wish to opt out of communications promoting this campaign, please use the provided opt-out link here.

For details on how we process your personal data, see our Privacy Statement

Get Access

Real-world diagnostic testing data, including results at a patient level, updated weekly enabling up to date deeper analysis

Download Brochure